New management guidelines for PsA use GRADE methodology
The ACR is about to release its first-ever guideline for the management of psoriatic arthritis (PsA). Written in conjunction with the National Psoriasis Foundation…
acrdailynewslive.org
TNF inhibitor biologics are recommended as first-line therapy.
mdedge.com
While the soon-to-be-revealed ACR-NPA guideline on PsA appears less comprehensive and prescriptive in recommending treatment modalities and targets for the various domains, especially skin (but then, precise information is still scarce for now), it is widely anticipated to favour early and aggressive treatment, to the benefit of patients.
TNF inhibitors are both first and second line for all domains, followed by anti-IL17, anti-IL12/23, before JAK inhibitors.
TNF inhibitors are both first and second line for all domains, followed by anti-IL17, anti-IL12/23, before JAK inhibitors.
Biologics more often led to remission in PsA vs conventional drugs
Among patients with psoriatic arthritis, biologics more often led to remission or minimal disease activity…
healio.com